SCOTTSDALE, AZ–(Marketwired – April 18, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (Lattice Biologics) to launch three new products utilizing its patent pending matrix-assisted regeneration (MAR) platform. New products, MarBrane andMarGraft (expected to launch in Q2 2016) and MarCell (expected to launch in Q3 2016) are anticipated to significantly accelerate the company’s top line […]